Clinical Trial Update: Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous hyoscine butylbromide for effects on the first stage of labor in primigravidae has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Delivery

Drugs mentioned

• Hyoscine Butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Ahmed M Maged, MD | Conditions: Vaginal Delivery | Phase 4 | Status: COMPLETED